Get the Stockscreener App
0.59
1.27%
+0.0074
After Hours:
.5821
-0.0079
-1.34%
VBI Vaccines Inc. Stock (VBIV) Forecast
The VBI Vaccines Inc. (VBIV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $19.00, representing a +3,120% increase from the current price of $0.59. The highest analyst price target is $28.19, and the lowest is $9.7988.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VBIV Price Target
Average 23.50
(+3,883% Upside)
Is VBI Vaccines Inc. (VBIV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.59 | Neutral |
| STOCH(9,6) | 34.83 | Neutral |
| STOCHRSI(14) | 58.33 | Neutral |
| MACD(12,26) | -0.0136 | Sell |
| ADX(14) | 49.29 | Buy |
| William %R | -53.54 | Neutral |
| CCI(14) | -10.67 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5852
Buy
|
0.5885
Buy
|
| MA20 |
0.6168
Sell
|
0.6014
Sell
|
| MA50 |
0.6057
Sell
|
0.6129
Sell
|
| MA100 |
0.616
Sell
|
0.7245
Sell
|
| MA200 |
0.748
Sell
|
1.9363
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, VBIV could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 9 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on VBIV, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.59 indicates that VBIV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 34.83 indicates that VBIV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 58.33 indicates that VBIV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 49.29 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -10.67 indicates that VBIV is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term VBIV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about VBI Vaccines Inc. financial reports and earnings history, VBI Vaccines Inc. (VBIV) stock could reach $63.81 by 2030, $36.83 by 2040 and $91.78 by 2050. See the projected annual prices until 2050 of the VBI Vaccines Inc. stock below:
- VBI Vaccines Inc. (VBIV) is expected to reach an average price of $12.08 in 2035, with a high prediction of $13.70 and a low estimate of $12.16. This indicates an $1,948% rise from the last recorded price of $0.59.
- VBI Vaccines Inc. (VBIV) stock is projected to chart a bullish course in 2040, with an average price target of $37.20, representing an $6,206% surge from its current level. The forecast ranges from a conservative $37.67 to a sky-high $36.83.
- Our analysts predict VBI Vaccines Inc. (VBIV) to jump 10,059% by 2045, soaring from $60.35 to an average price of $59.94, potentially reaching $58.38. While $60.35 is the low estimate, the potential upside is significant.
- VBI Vaccines Inc. (VBIV) stock is expected to climb by 2050, reaching an average of $85.38, a $14,372% jump from its current level. However, a wide range of estimates exists, with high and low targets of $91.78 and $93.88, respectively, highlighting the market's uncertainty.
VBI Vaccines Inc. Stock (VBIV) Year by Year Forecast
VBI Vaccines Inc. Stock (VBIV) Price Forecast for 2024
Our forecast for VBIV stock price in 2024 now indicates an average price target of $20.98 with a high forecast of $41.42 and a low forecast of $0.53. The average prediction reflects an increase of +3,455% from the last recorded price of $0.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $24.69 | $9.7988 | $28.19 | +4,084% |
| July, 2024 | $36.80 | $32.88 | $35.55 | +6,137% |
| August, 2024 | $39.33 | $38.38 | $37.44 | +6,566% |
| September, 2024 | $41.95 | $40.32 | $39.18 | +7,011% |
| October, 2024 | $40.21 | $41.22 | $41.42 | +6,715% |
| November, 2024 | $38.60 | $38.05 | $37.45 | +6,442% |
| December, 2024 | $28.49 | $32.60 | $36.44 | +4,729% |
VBI Vaccines Inc. Stock (VBIV) Price Forecast for 2025
VBI Vaccines Inc. Stock (VBIV) is expected to reach an average price of $83.35 in 2025, with a high prediction of $161.11 and a low estimate of $5.5766. This indicates an +14,026% rise from the last recorded price of $0.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $13.94 | $17.60 | $24.31 | +2,263% |
| February, 2025 | $11.46 | $5.5766 | $6.4234 | +1,843% |
| March, 2025 | $15.74 | $6.5512 | $7.9385 | +2,568% |
| April, 2025 | $22.21 | $15.53 | $25.32 | +3,664% |
| May, 2025 | $2.1814 | $9.3814 | $19.30 | +269.72% |
| June, 2025 | $7.644 | $8.856 | $19.94 | +1,196% |
| July, 2025 | $38.68 | $7.0631 | $40.55 | +6,455% |
| August, 2025 | $70.40 | $26.28 | $84.80 | +11,832% |
| September, 2025 | $80.98 | $65.85 | $161.11 | +13,625% |
| October, 2025 | $54.26 | $40.95 | $110.25 | +9,096% |
| November, 2025 | $41.28 | $39.58 | $77.77 | +6,897% |
| December, 2025 | $27.02 | $24.62 | $49.70 | +4,479% |
VBI Vaccines Inc. Stock (VBIV) Price Forecast for 2026
The predicted value for VBI Vaccines Inc. (VBIV) in 2026 is set at an average of $61.87. Estimates vary from a peak of $104.72 to a trough of $19.03, indicating an +10,387% surge from the present price of $0.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $44.34 | $19.03 | $47.67 | +7,415% |
| February, 2026 | $55.22 | $46.05 | $65.75 | +9,259% |
| March, 2026 | $55.74 | $38.89 | $75.39 | +9,348% |
| April, 2026 | $70.72 | $47.10 | $104.72 | +11,887% |
| May, 2026 | $66.75 | $40.84 | $74.83 | +11,213% |
| June, 2026 | $46.27 | $45.67 | $72.36 | +7,743% |
| July, 2026 | $50.31 | $36.21 | $60.57 | +8,426% |
| August, 2026 | $81.73 | $47.51 | $89.23 | +13,753% |
| September, 2026 | $61.46 | $55.18 | $93.45 | +10,317% |
| October, 2026 | $57.79 | $49.97 | $62.57 | +9,695% |
| November, 2026 | $74.51 | $47.70 | $78.41 | +12,529% |
| December, 2026 | $60.55 | $58.93 | $80.72 | +10,162% |
VBI Vaccines Inc. Stock (VBIV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for VBI Vaccines Inc. (VBIV) is $36.05, with a high forecast of $71.97 and a low forecast of $0.1331. This indicates an +6,010% increase from the last price of $0.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $59.27 | $55.35 | $65.27 | +9,946% |
| February, 2027 | $58.30 | $52.88 | $64.78 | +9,781% |
| March, 2027 | $44.63 | $32.42 | $71.97 | +7,464% |
| April, 2027 | $32.25 | $26.59 | $46.63 | +5,367% |
| May, 2027 | $18.08 | $15.27 | $31.56 | +2,964% |
| June, 2027 | $11.91 | $8.4978 | $23.39 | +1,919% |
| July, 2027 | $23.24 | $10.62 | $29.24 | +3,838% |
| August, 2027 | $14.76 | $14.54 | $29.35 | +2,402% |
| September, 2027 | $2.7761 | $0.1331 | $17.67 | +370.52% |
| October, 2027 | $3.8056 | $0.5031 | $7.1121 | +545.01% |
| November, 2027 | $2.1918 | $0.1375 | $6.9248 | +271.50% |
| December, 2027 | $14.58 | $0.3312 | $15.33 | +2,370% |
VBI Vaccines Inc. Stock (VBIV) Price Forecast for 2028
In 2028, VBI Vaccines Inc. (VBIV) is projected to reach an average price of $9.3446, with a high projection of $18.68 and a low estimate of $0.00729. This indicates an +1,484% rise from the last price of $0.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.591 | $4.3946 | $18.68 | +847.62% |
| February, 2028 | $0.8004 | $0.42 | $6.2137 | +35.65% |
| March, 2028 | $2.2611 | $0.00729 | $2.8431 | +283.24% |
| April, 2028 | $1.1765 | $0.8356 | $3.0734 | +99.41% |
| May, 2028 | $5.0468 | $2.7102 | $3.4868 | +755.38% |
| June, 2028 | $1.4096 | $0.1594 | $4.8404 | +138.92% |
| July, 2028 | $2.355 | $0.46 | $4.6597 | +299.15% |
| August, 2028 | $4.3772 | $0.0276 | $2.7324 | +641.91% |
| September, 2028 | $9.8699 | $5.5149 | $4.4386 | +1,573% |
| October, 2028 | $10.37 | $10.50 | $10.15 | +1,658% |
| November, 2028 | $9.2697 | $9.3997 | $9.6451 | +1,471% |
| December, 2028 | $8.0043 | $9.247 | $8.9734 | +1,257% |
VBI Vaccines Inc. Stock (VBIV) Price Forecast for 2029
The 2029 price forecast for VBI Vaccines Inc. Stock (VBIV) is $29.84 on average, with a high prediction of $59.46 and a low estimate of $0.2136. This represents an +4,957% increase from the previous price of $0.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.9526 | $8.9826 | $9.3416 | +1,417% |
| February, 2029 | $8.2072 | $8.2372 | $8.7262 | +1,291% |
| March, 2029 | $7.5118 | $7.6018 | $7.9809 | +1,173% |
| April, 2029 | $7.2264 | $7.2654 | $7.4591 | +1,125% |
| May, 2029 | $6.1547 | $6.1637 | $6.9801 | +943.17% |
| June, 2029 | $5.3152 | $5.3293 | $5.8496 | +800.88% |
| July, 2029 | $4.5164 | $4.5539 | $4.9954 | +665.49% |
| August, 2029 | $3.3722 | $3.4522 | $4.2602 | +471.55% |
| September, 2029 | $2.6767 | $2.6966 | $3.1308 | +353.67% |
| October, 2029 | $1.6398 | $1.66 | $2.4415 | +177.94% |
| November, 2029 | $0.7559 | $0.8396 | $1.3957 | +28.13% |
| December, 2029 | $60.66 | $0.2136 | $59.46 | +10,182% |
VBI Vaccines Inc. Stock (VBIV) Price Forecast for 2030
VBI Vaccines Inc. Stock (VBIV) is expected to reach an average price of $78.33 in 2030, with a high forecast of $98.11 and a low forecast of $58.55. This signifies an +13,177% surge from the last price of $0.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $63.70 | $63.55 | $63.81 | +10,696% |
| February, 2030 | $93.27 | $88.97 | $88.75 | +15,709% |
| March, 2030 | $96.86 | $95.53 | $94.90 | +16,317% |
| April, 2030 | $97.22 | $97.18 | $95.95 | +16,377% |
| May, 2030 | $99.25 | $98.12 | $98.11 | +16,721% |
| June, 2030 | $92.51 | $96.13 | $96.47 | +15,579% |
| July, 2030 | $90.45 | $92.44 | $92.91 | +15,231% |
| August, 2030 | $78.66 | $81.57 | $80.50 | +13,233% |
| September, 2030 | $57.47 | $68.57 | $65.90 | +9,640% |
| October, 2030 | $58.40 | $58.55 | $56.83 | +9,799% |
| November, 2030 | $79.55 | $61.29 | $66.05 | +13,384% |
| December, 2030 | $70.70 | $75.31 | $76.44 | +11,883% |
1.62%
0.15%
Cap:
|
Volume (24h):